{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:58:32Z","timestamp":1792587512743,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mucormycosis is an invasive fungal infection with high morbidity and mortality rate despite the early diagnosis and proper therapeutic interventions. Given the importance of epidemiological data in reviewing the attitude toward infectious diseases in developing countries, the current retrospective case study aimed to compare the epidemiological aspects, risk factors, clinical characteristics, therapeutic interventions, and outcomes of mucormycosis between adults and children during eight years (2013\u20132021) in the main infectious disease referral centers in the southwest of Iran. The median age of 164 patients included in this study was 47\u00a0years (IQR 22\u201359). The median length of hospitalization was 33\u00a0days.The annual incidence of mucormycosis-related hospitalizations was estimated 1.76 per 10,000 admissions during the study period. Moreover, the incidence of infection was 2.4 times higher in males than females in children. Diabetes mellitus was the most frequent predisposing factor in adults\u00a0(46.0%). The main risk factor in children was hematologic malignancy (52.6%), but a considerable proportion of them (28.9%) were immunocompetent.The most frequent antifungal agent used was liposomal amphotericin B (82.3%) as monotherapy. The combination therapy was used more in adults (15.8%) than children (7.9%). In addition, surgical intervention with antifungal therapy was considered the most effective therapeutic approach. The in-hospital mortality rate was 14.6% for adults, whereas it was zero for children. Our findings provide a recent epidemiologic analysis of mucormycosis among hospitalized patients in both children and adults. Mucormycosis mainly affects individuals with diabetes mellitus or hematological malignancies and presents as rhino-orbito-cerebral form. Proven diagnosis of mucormycosis according to clinical manifestations and histopathology observations accompanied by proper antifungal treatments may improve survival rates.<\/jats:p>","DOI":"10.1038\/s41598-022-21611-8","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T11:03:20Z","timestamp":1665659000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epidemiology, clinical features, therapeutic interventions\u00a0and outcomes of mucormycosis in Shiraz: an 8-year retrospective case study with comparison between children and adults"],"prefix":"10.1038","volume":"12","author":[{"given":"Marjan","family":"Motamedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Golmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mojtaba","family":"Saneian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Shafiekhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"issue":"suppl 1","key":"21611_CR1","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","volume":"54","author":"G Petrikkos","year":"2012","unstructured":"Petrikkos, G. et al. Epidemiology and clinical manifestations of mucormycosis. Clin. Infect. Dis. 54(suppl 1), S23\u2013S34 (2012).","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"21611_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmi.2014.12.021","volume":"21","author":"M Slavin","year":"2015","unstructured":"Slavin, M. et al. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clin. Microbiol. Infect. 21(5), 490 (2015).","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"21611_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","volume":"5","author":"H Prakash","year":"2019","unstructured":"Prakash, H. & Chakrabarti, A. Global epidemiology of mucormycosis. J. Fungi. 5(1), 26 (2019).","journal-title":"J. Fungi."},{"issue":"4","key":"21611_CR4","doi-asserted-by":"publisher","first-page":"e1005491","DOI":"10.1371\/journal.ppat.1005491","volume":"12","author":"A Chowdhary","year":"2016","unstructured":"Chowdhary, A., Agarwal, K. & Meis, J. F. Filamentous fungi in respiratory infections: What lies beyond Aspergillosis and Mucormycosis?. PLoS Pathog. 12(4), e1005491 (2016).","journal-title":"PLoS Pathog."},{"issue":"12","key":"21611_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/myc.12529","volume":"59","author":"A Manesh","year":"2016","unstructured":"Manesh, A. et al. Posaconazole: An emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis. Mycoses 59(12), 765\u2013772 (2016).","journal-title":"Mycoses"},{"issue":"1","key":"21611_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong, W. et al. The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports. Clin. Microbiol. Infect. 25(1), 26\u201334 (2019).","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"21611_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","volume":"16","author":"FM Marty","year":"2016","unstructured":"Marty, F. M. et al. Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis. Lancet. Infect. Dis 16(7), 828\u2013837 (2016).","journal-title":"Lancet. Infect. Dis"},{"issue":"9","key":"21611_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/myc.12958","volume":"62","author":"M Nucci","year":"2019","unstructured":"Nucci, M., Engelhardt, M. & Hamed, K. Mucormycosis in South America: A review of 143 reported cases. Mycoses 62(9), 730\u2013738 (2019).","journal-title":"Mycoses"},{"issue":"3","key":"21611_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/microorganisms9030523","volume":"9","author":"H Prakash","year":"2021","unstructured":"Prakash, H. & Chakrabarti, A. Epidemiology of mucormycosis in India. Microorganisms. 9(3), 523 (2021).","journal-title":"Microorganisms."},{"issue":"4","key":"21611_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/myc.13222","volume":"64","author":"A Bonifaz","year":"2021","unstructured":"Bonifaz, A. et al. Mucormycosis at a tertiary-care center in Mexico: A 35-year retrospective study of 214 cases. Mycoses 64(4), 372\u2013380 (2021).","journal-title":"Mycoses"},{"key":"21611_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/myc.12233","volume":"57","author":"A Bonifaz","year":"2014","unstructured":"Bonifaz, A. et al. Mucormycosis in children: a study of 22 cases in a Mexican hospital. Mycoses 57, 79\u201384 (2014).","journal-title":"Mycoses"},{"issue":"7","key":"21611_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/339202","volume":"34","author":"KA Marr","year":"2002","unstructured":"Marr, K. A., Carter, R. A., Crippa, F., Wald, A. & Corey, L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34(7), 909\u2013917 (2002).","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"21611_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/jof6040265","volume":"6","author":"A Skiada","year":"2020","unstructured":"Skiada, A., Pavleas, I. & Drogari-Apiranthitou, M. Epidemiology and diagnosis of mucormycosis: An update. J. Fungi. 6(4), 265 (2020).","journal-title":"J. Fungi."},{"issue":"1","key":"21611_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-2023-z","volume":"16","author":"DP Kontoyiannis","year":"2016","unstructured":"Kontoyiannis, D. P. et al. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: A retrospective study. BMC Infect. Dis. 16(1), 1\u20136 (2016).","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"21611_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/23744235.2016.1239027","volume":"49","author":"J Chander","year":"2017","unstructured":"Chander, J. et al. Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections\u2013a study from a tertiary care hospital in north India. Infect. Dis. 49(3), 170\u2013177 (2017).","journal-title":"Infect. Dis."},{"issue":"10","key":"21611_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3855\/jidc.10476","volume":"12","author":"MT Hedayati","year":"2018","unstructured":"Hedayati, M. T. et al. Burden of fungal infections in Iran. J. Infect. Dev. Countries. 12(10), 910\u2013918 (2018).","journal-title":"J. Infect. Dev. Countries."},{"issue":"7","key":"21611_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/myc.12474","volume":"59","author":"A Vaezi","year":"2016","unstructured":"Vaezi, A., Moazeni, M., Rahimi, M. T., de Hoog, S. & Badali, H. Mucormycosis in Iran: A systematic review. Mycoses 59(7), 402\u2013415 (2016).","journal-title":"Mycoses"},{"issue":"6","key":"21611_CR18","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1111\/j.1439-0507.2011.02025.x","volume":"54","author":"J D\u00e4britz","year":"2011","unstructured":"D\u00e4britz, J. et al. Mucormycosis in paediatric patients: Demographics, risk factors and outcome of 12 contemporary cases. Mycoses 54(6), e785\u2013e788 (2011).","journal-title":"Mycoses"},{"issue":"2","key":"21611_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mycmed.2018.02.014","volume":"28","author":"S Dolatabadi","year":"2018","unstructured":"Dolatabadi, S. et al. Mucormycosis in Iran: A six-year retrospective experience. J. Mycol. Med. 28(2), 269\u2013273 (2018).","journal-title":"J. Mycol. Med."},{"issue":"1","key":"21611_CR20","first-page":"221","volume":"12","author":"R Nashibi","year":"2017","unstructured":"Nashibi, R., Afzalzadeh, S., Mohammadi, M. J., Yari, A. R. & Yousefi, F. Epidemiology and treatment outcome of mucormycosis in Khuzestan, Southwest of Iran. Arch. Clin. Infect. Dis. 12(1), 221 (2017).","journal-title":"Arch. Clin. Infect. Dis."},{"issue":"7","key":"21611_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/myc.12614","volume":"60","author":"R Samarei","year":"2017","unstructured":"Samarei, R., Gharebaghi, N. & Zayer, S. Evaluation of 30 cases of mucormycosis at a university hospital in Iran. Mycoses 60(7), 426\u2013432 (2017).","journal-title":"Mycoses"},{"issue":"1","key":"21611_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1067\/mhn.2002.126587","volume":"127","author":"YP Talmi","year":"2002","unstructured":"Talmi, Y. P. et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol. Head Neck Surg. 127(1), 22\u201331 (2002).","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"4","key":"21611_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/13693780500464930","volume":"44","author":"A Chakrabarti","year":"2006","unstructured":"Chakrabarti, A. et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Sabouraudia 44(4), 335\u2013342 (2006).","journal-title":"Sabouraudia"},{"issue":"3","key":"21611_CR24","first-page":"76","volume":"2","author":"RI El-Herte","year":"2012","unstructured":"El-Herte, R. I., Baban, T. A. & Kanj, S. S. Mucormycosis: A review on environmental fungal spores and seasonal variation of human disease. Adv. Infect. Dis. 2(3), 76\u201381 (2012).","journal-title":"Adv. Infect. Dis."},{"issue":"1","key":"21611_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/mmy\/myx017","volume":"56","author":"DE Corzo-Le\u00f3n","year":"2018","unstructured":"Corzo-Le\u00f3n, D. E., Chora-Hern\u00e1ndez, L. D., Rodr\u00edguez-Zulueta, A. P. & Walsh, T. J. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases. Med. Mycol. 56(1), 29\u201343 (2018).","journal-title":"Med. Mycol."},{"issue":"3","key":"21611_CR26","first-page":"175","volume":"7","author":"M Moghaddaml","year":"1993","unstructured":"Moghaddaml, M., Mohraz, M. & Shidfar, M. Report of thirteen cases of mucormycosis. MJIRI. 7(3), 175\u2013178 (1993).","journal-title":"MJIRI."},{"key":"21611_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1470-9465.2004.00843.x","volume":"10","author":"R Prabhu","year":"2004","unstructured":"Prabhu, R. & Patel, R. Mucormycosis and entomophthoramycosis: A review of the clinical manifestations, diagnosis and treatment. Clin. Microbiol. Infect. 10, 31\u201347 (2004).","journal-title":"Clin. Microbiol. Infect."},{"key":"21611_CR28","first-page":"10","volume":"13","author":"M Khanna","year":"2021","unstructured":"Khanna, M. et al. Risk of mucormycosis in diabetes mellitus: A systematic review. Cureus. 13, 10 (2021).","journal-title":"Cureus."},{"issue":"1","key":"21611_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12281-019-0337-1","volume":"13","author":"S Challa","year":"2019","unstructured":"Challa, S. Mucormycosis: Pathogenesis and pathology. Curr. Fung. Infect. Rep. 13(1), 11\u201320 (2019).","journal-title":"Curr. Fung. Infect. Rep."},{"issue":"5","key":"21611_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden, M. M. et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin. Infect. Dis. 41(5), 634\u2013653 (2005).","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"21611_CR31","first-page":"207","volume":"89","author":"L Pagano","year":"2004","unstructured":"Pagano, L. et al. Mucormycosis in hematologic patients. Haematologica 89(2), 207\u2013214 (2004).","journal-title":"Haematologica"},{"issue":"2","key":"21611_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jac\/dkp430","volume":"65","author":"MJ Rueping","year":"2010","unstructured":"Rueping, M. J. et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J. Antimicrob. Chemother. 65(2), 296\u2013302 (2010).","journal-title":"J. Antimicrob. Chemother."},{"issue":"suppl 1","key":"21611_CR33","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/cid\/cir865","volume":"54","author":"AS Ibrahim","year":"2012","unstructured":"Ibrahim, A. S., Spellberg, B., Walsh, T. J. & Kontoyiannis, D. P. Pathogenesis of mucormycosis. Clin. Infect. Dis. 54(suppl 1), S16\u2013S22 (2012).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"21611_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-2005-1","volume":"16","author":"ZD Pana","year":"2016","unstructured":"Pana, Z. D. et al. Invasive mucormycosis in children: An epidemiologic study in European and non-European countries based on two registries. BMC Infect. Dis. 16(1), 1\u20139 (2016).","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"21611_CR35","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1016\/j.ijid.2011.02.005","volume":"15","author":"MD Mignogna","year":"2011","unstructured":"Mignogna, M. D. et al. Mucormycosis in immunocompetent patients: A case-series of patients with maxillary sinus involvement and a critical review of the literature. Int. J. Infect. Dis. 15(8), e533\u2013e540 (2011).","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"21611_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05460-2","volume":"20","author":"A Amanati","year":"2020","unstructured":"Amanati, A. et al. Orbital mucormycosis in immunocompetent children: Review of risk factors, diagnosis, and treatment approach. BMC Infect. Dis. 20(1), 1\u20139 (2020).","journal-title":"BMC Infect. Dis."},{"key":"21611_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.mmcr.2019.07.007","volume":"26","author":"M Nidhi","year":"2019","unstructured":"Nidhi, M., Sadia, K., Khatri, A., Arnab, G. & Khan, N. A. Gastrointestinal mucormycosis in a two-year-old child: A clinical and radiological enigma. Med. Mycol. Case Rep. 26, 5\u20139 (2019).","journal-title":"Med. Mycol. Case Rep."},{"issue":"4","key":"21611_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12281-015-0236-z","volume":"9","author":"A Bonifaz","year":"2015","unstructured":"Bonifaz, A., Tirado-S\u00e1nchez, A., Calder\u00f3n, L. & Ponce, R. M. Cutaneous mucormycosis: Mycological, clinical, and therapeutic aspects. Curr. Fung. Infect. Rep. 9(4), 229\u2013237 (2015).","journal-title":"Curr. Fung. Infect. Rep."},{"issue":"4","key":"21611_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/jinf.2001.0831","volume":"42","author":"A Chakrabarti","year":"2001","unstructured":"Chakrabarti, A. et al. Ten years\u2019 experience in zygomycosis at a tertiary care centre in India. J. Infect. 42(4), 261\u2013266 (2001).","journal-title":"J. Infect."},{"issue":"suppl 1","key":"21611_CR40","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/cid\/cir868","volume":"54","author":"TJ Walsh","year":"2012","unstructured":"Walsh, T. J., Gamaletsou, M. N., McGinnis, M. R., Hayden, R. T. & Kontoyiannis, D. P. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin. Infect. Dis. 54(suppl 1), S55\u2013S60 (2012).","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"21611_CR41","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely, O. A. et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet. Infect. Dis 19(12), e405\u2013e421 (2019).","journal-title":"Lancet. Infect. Dis"},{"issue":"3","key":"21611_CR42","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1007\/s12070-018-1530-1","volume":"71","author":"R Mane","year":"2019","unstructured":"Mane, R., Patil, B., Mohite, A. & Mohanty, R. Facial nerve palsy: An unusual presentation in patients with rhino cerebral mucormycosis. Indian J. Otolaryngol. Head Neck Surg. 71(3), 2110\u20132113 (2019).","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"issue":"12","key":"21611_CR43","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw, B. et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group. Clin. Infect. Dis. 46(12), 1813\u20131821 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"21611_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12371","volume":"20","author":"O Cornely","year":"2014","unstructured":"Cornely, O. et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin. Microbiol. Infect. 20, 5\u201326 (2014).","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"21611_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","volume":"50","author":"R Greenberg","year":"2006","unstructured":"Greenberg, R. et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob. Agents Chemother. 50(1), 126\u2013133 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"21611_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijantimicag.2019.01.002","volume":"53","author":"W Jeong","year":"2019","unstructured":"Jeong, W. et al. Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports. Int. J. Antimicrob. Agents 53(5), 589\u2013597 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"suppl 1","key":"21611_CR47","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1093\/cid\/cir880","volume":"54","author":"F Lanternier","year":"2012","unstructured":"Lanternier, F. et al. A global analysis of mucormycosis in France: The RetroZygo Study (2005\u20132007). Clin. Infect. Dis. 54(suppl 1), S35\u2013S43 (2012).","journal-title":"Clin. Infect. Dis."},{"issue":"1009","key":"21611_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","volume":"85","author":"A Chakrabarti","year":"2009","unstructured":"Chakrabarti, A. et al. Invasive zygomycosis in India: Experience in a tertiary care hospital. Postgrad. Med. J. 85(1009), 573\u2013581 (2009).","journal-title":"Postgrad. Med. J."},{"key":"21611_CR49","unstructured":"Leaf-nosed bat. Encyclop\u00e6dia Britannica: Encyclop\u00e6dia Britannica Online (2009)."},{"issue":"8","key":"21611_CR50","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/INF.0b013e318062115c","volume":"26","author":"TE Zaoutis","year":"2007","unstructured":"Zaoutis, T. E. et al. Zygomycosis in children: A systematic review and analysis of reported cases. Pediatr. Infect. Dis. J. 26(8), 723\u2013727 (2007).","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"21611_CR51","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1086\/589857","volume":"47","author":"C Reed","year":"2008","unstructured":"Reed, C. et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin. Infect. Dis. 47(3), 364\u2013371 (2008).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"21611_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/pharmaceutics12010029","volume":"12","author":"C Faustino","year":"2020","unstructured":"Faustino, C. & Pinheiro, L. Lipid systems for the delivery of amphotericin B in antifungal therapy. Pharmaceutics. 12(1), 29 (2020).","journal-title":"Pharmaceutics."},{"key":"21611_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1469-0691.2009.02987.x","volume":"15","author":"G Petrikkos","year":"2009","unstructured":"Petrikkos, G. Lipid formulations of amphotericin B as first-line treatment of zygomycosis. Clin. Microbiol. Infect. 15, 87\u201392 (2009).","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"21611_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2146\/ajhp070532","volume":"66","author":"MI Morris","year":"2009","unstructured":"Morris, M. I. Posaconazole: A new oral antifungal agent with an expanded spectrum of activity. Am. J. Health Syst. Pharm. 66(3), 225\u2013236 (2009).","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"4","key":"21611_CR55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/mmy\/myy060","volume":"57","author":"H Prakash","year":"2019","unstructured":"Prakash, H. et al. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med. Mycol. 57(4), 395\u2013402 (2019).","journal-title":"Med. Mycol."},{"issue":"12","key":"21611_CR56","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3855\/jidc.12997","volume":"14","author":"P Badiee","year":"2020","unstructured":"Badiee, P., Jafarian, H. & Ghasemi, F. Molecular epidemiology of zygomycosis and their related factors in tertiary referral centers in southern Iran. J. Infect. Dev. Countries. 14(12), 1424\u20131430 (2020).","journal-title":"J. Infect. Dev. Countries."},{"issue":"5","key":"21611_CR57","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/myc.13245","volume":"64","author":"H Kato","year":"2021","unstructured":"Kato, H., Foster, C. M. & Karri, K. Incidence, predisposing conditions and outcomes of cutaneous mucormycosis: A national database study. Mycoses 64(5), 569\u2013572 (2021).","journal-title":"Mycoses"},{"issue":"10","key":"21611_CR58","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/myc.12954","volume":"62","author":"A Multani","year":"2019","unstructured":"Multani, A. et al. Cut it out! Thoracic surgeon\u2019s approach to pulmonary mucormycosis and the role of surgical resection in survival. Mycoses 62(10), 893\u2013907 (2019).","journal-title":"Mycoses"},{"issue":"2","key":"21611_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jpids\/pix107","volume":"7","author":"JR Francis","year":"2018","unstructured":"Francis, J. R., Villanueva, P., Bryant, P. & Blyth, C. C. Mucormycosis in children: Review and recommendations for management. J. Pediatr. Infect. Dis. Soc. 7(2), 159\u2013164 (2018).","journal-title":"J. Pediatr. Infect. Dis. Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21611-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21611-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21611-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T12:46:01Z","timestamp":1665665161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21611-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21611"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21611-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17174"}}